3 transcripts
CRNX
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
health care practitioners who are responsible for the vast majority of prescriptions.
These providers can be reached with a small sales force
CRNX
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
with paltusotine compared to placebo have now been documented in 2 major independent controlled trials. As previously discussed, we are very excited
CRNX
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
will actually normalize, but it is known that the majority of patients treated with an SRL in previous studies benefited from therapy.For regulatory
- Prev
- 1
- Next